參考文獻(xiàn)/References:
[1] 胡誕寧.近視眼學(xué)[M].北京:人民衛(wèi)生出版社,2009:3-4.
[2] 中華醫(yī)學(xué)會(huì)眼科學(xué)分會(huì)眼視光學(xué)組.重視高度近視防控的專家共識(shí)(2017)[J].中華眼科學(xué)與視光學(xué)雜志,2017,19(7):385-389.
[3] Ikuno Y S.Overview of the complications of high myopia[J].Retina,2017,37(12):2347-2351.
[4] Brien A, Holden T, Fricke R, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050[J].Ophthalmology,2017,124(3):24-25.
[5] Robert W, Cheng C Y. Involvement of multiple molecular pathways in the genetics of ocular refraction and myopia[J].Retina,2018,38(1):91-101.
[6] Jones-Jordan L A,Sinnott L T,Manny R E,et al. Early childhood refractive error and parental history of myopia as predictors of myopia[J]. Invest Ophthalmol Vis Sci,2010,51(8):115-121.
[7] Giloyan A,Harutyunyan T,Petrosyan V.Risk factors for developing myopia among schoolchildren in Yerevan and Gegharkunik province, Armenia[J].Ophthalmic Epidemio,2017,24(2):97-103.
[8] Smith E L,Harwerth R S,Crawford M L,et al. Observations on the effects of form deprivation on the refractive status of the monkey[J]. Invest Ophthalmol Vis Sci,1987,28(8):1236-1245.
[9] Chia A, Chua W H, Wen L, et al. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%[J]. Ophthalmology,2014,157(2):451-457.
[10] Galvis V, Tello A, Parra M M. Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops[J]. Ophthalmology,2016,123(2):391-399.
[11] Clark T Y, Clark R A. Atropine 0.01% eyedrops significantly reduce the progression of childhood myopia[J]. J Ocul Pharmacol Ther,2015,31(9):541-545.
[12] Michael R S,Cotter S A, Crocket R S,et al. Two-year multicenter,randomized,double-masked,placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia[J].Jaapos,2008,12(4):332-339.
[13] Trier K, Ribel-Madsen S M,Cui D, et al. Systemic 7-methylxanthine in retarding axial eye growth and myopia progression: a 36-month pilot study[J]. J Ocul Biol Dis Infor,2008,1(2/4):85-93.
[14] Hung L F, Arumugam B, Ostrin L, et al. The adenosine receptor antagonist,7-methylxanthine,alters emmetropizing responses in infant macaques[J]. Iovs,2018,59(1):472-486.
[15] Gwiazda J E,Hyman L,Norton T T, et al. Accommodation and related risk factors associated with myopia progression and their interaction with treatment COMET children[J]. Invest Ophthalmol Vis Sic,2004,45(7):2141-2153.
[16] Chen Z, Xue F, Zhou J, et al. Effects of orthokeratology on choroidal thickness and axial length[J]. Optom Vis Sci,2016,93(9):1064-1071.
[17] Yuan S, Xu F,Zhang T,et al. Orthokeratology to control myopia progression: a meta-analysis[J].PLoS One,2015,10(6):e0130646
[18] Liu Y M, Xie P.The safety of orthokeratology-a systematic review[J].Eye Contact Lens,2016,42(1):35-42.
[19] Shen Z M, Zhang Z Z, Zhang L Y,et al. Posterior scleral reinforcement combined with patching therapy for pre-school children with unilateral high myopia[J].Graefes Arch Clin Exp Ophthalmol, 2015,253(8):1391-1395.
[20] Rose K A,Morgan I G,Ip J,et a1.Outdoor activity reduces the prevalence of myopia in children[J].Ophthalmology,2008,1(15):1279-1285.
[21] He M,Xiang F, Zeng Y,et al. Effect of time spent outdoors at school on the development of myopia among children in China: a randomized clinical trial[J].JAMA,2015,314(11):1142-1148.
[22] Wu P C, Chen C T, Lin K K,et al. Myopia prevention and outdoor light intensity in a school-based cluster randomized trial[J].Ophthalmology,2018,125(8):1239-1250.